Hemp legalization once again dominated this week’s headlines as media sources report how changes to U.S. hemp policy will affect domestic industries.
CBD gift guides, national hemp legalization, and the NFL’s enduring CTE epidemic were just some of the trending topics this week as Medical Marijuana, Inc. and our portfolio of companies continue our diverse approach to taking advantage of CBD’s wellness potential.
CNBC Includes Medical Marijuana, Inc. in Coverage of 2018 Farm Bill
In a story looking at the potential effects of the 2018 Farm Bill and its provision to legalize hemp nationwide in the U.S., CNBC included Medical Marijuana, Inc. as one of three top CBD companies poised to take advantage of a booming CBD market. Experts anticipate the CBD industry will be worth over $1 billion in the first year of legalization before ballooning to $22 billion within 4 years.
You can find more about the passing of the 2018 Farm Bill here.
Dr. Titus Interviewed by 10 News San Diego
Following news that President Trump signed the 2018 Farm Bill into law, officially legalizing hemp in the U.S. nationwide, local network news 10 News San Diego interviewed Medical Marijuana, Inc. CEO Dr. Stuart Titus about the impact this change will have on companies like Medical Marijuana, Inc. who operate in the hemp space.
“We really think this is going to be a tremendous growth market over the next three to five years,” Dr. Titus told the network.
Want to learn more about the 2018 Farm Bill will affect Medical Marijuana, Inc.? Click here.
Experts Highlight Medical Marijuana, Inc.
Following news of the 2018 Farm Bill’s passing, several investment websites listed Medical Marijuana, Inc. as a smart hemp industry investment. Spotlight Growth and Investopedia included Medical Marijuana, Inc. in its list of hemp businesses in which to invest for 2019.
According to experts, the CBD industry is expected to soar to $22 billion by 2022 due to its national legalization in the U.S. An innovator in the hemp and CBD industries, Medical Marijuana, Inc. is excited for the new opportunities presented with the changes to U.S. hemp policy.
You can learn more about investing in Medical Marijuana, Inc. here.
Kannalife Sciences Works to Minimize NFL’s CTE Epidemic
Former All-Pro NFL kicker and Kannalife™ Sciences spokesperson Nick Lowery understands the very real consequences of CTE (Chronic Traumatic Encephalopathy). He has seen his friends and colleagues in the NFL suffer from its effects. That is what drives him to educate the American public and his fellow football players about CTE and CBD’s potential role in this issue.
UPI took up this story this week with their article, “Ex-NFL star working on ‘intercellular’ helmet to curb concussions, CTE”. Lowery was interviewed as part of this article to provide insight into how CTE affects former and active NFL players and how Kannalife™ is exploring ways to use CBD to create a treatment option.
“How can we allow this to happen? And it’s not because football is the worst sport. It’s the best sport … but the bottom line is how can we let this happen to future Mike Websters,” Lowery told UPI. “What can we do to make sure this doesn’t happen and preserve this game? Who are the stewards of the game if it’s not us?”
Kannalife™ Sciences is working under its exclusive licenses from the National Institutes of Health for the commercialization of U.S. Patent #6,630,507, “Cannabinoids as Antioxidants and Neuroprotectants” to create an FDA approved cannabinoid-based treatment for CTE. With this goal in mind, the company has developed a synthetic CBD-like molecule, KLS-13019, which is 50 times more potent and 400 times less toxic than naturally occurring CBD.
“What’s hurting the game is simply not figuring out how we reduce the impact of concussions and these hits that are part of football … There is very consistent and powerful evidence that we are on the right track,” Lowery said of the work being done by Kannalife™.
You can find the full article here.
Medical Marijuana, Inc. Products Featured in Product Guides
Products from the Medical Marijuana, Inc. portfolio of companies were included in gift and product buyers guides this past couple weeks, as CBD use continues to spread in mainstream culture.
Dixie Botanicals® Salvation Balm CBD topical, Phyto Animal Health THC-Free Vitality-X™ for pets and livestock animals, and Cannabis Beauty Defined Anti-Aging Exfoliant were a part of the Los Angeles Blade’s holiday gift guide, titled “Last Minute Gift-Giving Made Easy”.
Pet’s Plus Magazine also featured Phyto Animal Health products in the form of the company’s HempBone Bacon Apple Donuts in their recent buyers guide, “CBD Roundup: Edibles and Topicals for Dogs and Cats”.